1 – 39 of 39
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Phenotypic characterization of spatial immune infiltration niches in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases
2023) In Virchows Archiv(
- Contribution to journal › Article
-
Mark
KRAS G12C Mutant Non–Small Cell Lung Cancer Linked to Female Sex and High Risk of CNS Metastasis : Population-based Demographics and Survival Data From the National Swedish Lung Cancer Registry
(
- Contribution to journal › Article
-
Mark
Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms
(
- Contribution to journal › Scientific review
-
Mark
Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Fibroblast subsets in non-small cell lung cancer : associations with survival, mutations, and immune features
(
- Contribution to journal › Article
-
Mark
An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
(
- Contribution to journal › Article
- 2022
-
Mark
Trailblazing precision medicine in Europe : A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany
(
- Contribution to journal › Article
-
Mark
Implementing precision medicine in a regionally organized healthcare system in Sweden
(
- Contribution to journal › Letter
- 2021
-
Mark
Molekylär patologi – nyckeln till målinriktad cancerbehandling
(
- Contribution to journal › Article
-
Mark
FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response
(
- Contribution to journal › Article
-
Mark
PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung
(
- Contribution to journal › Article
-
Mark
Evaluation of NTRK immunohistochemistry as a screening method for NTRK gene fusion detection in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
The prognostic impact of the tumour stroma fraction : A machine learning-based analysis in 16 human solid tumour types
(
- Contribution to journal › Article
- 2020
-
Mark
Diagnostic value of insulinoma-associated protein 1 (INSM1) and comparison with established neuroendocrine markers in pulmonary cancers
(
- Contribution to journal › Article
-
Mark
Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non-small cell lung cancer
(
- Contribution to journal › Article
- 2019
-
Mark
Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases
(
- Contribution to journal › Article
-
Mark
Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11
(
- Contribution to journal › Article
-
Mark
A clonal expression biomarker associates with lung cancer mortality
(
- Contribution to journal › Letter
- 2018
-
Mark
Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases
(
- Contribution to journal › Article
-
Mark
Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer
(
- Contribution to journal › Article
- 2017
-
Mark
Gene expression profiling of large cell lung cancer links transcriptional phenotypes to the new histological WHO2015 classification
(
- Contribution to journal › Article
-
Mark
Reaching the limits of prognostication in non-small cell lung cancer : an optimized biomarker panel fails to outperform clinical parameters
(
- Contribution to journal › Article
- 2016
-
Mark
The impact of the fourth edition of the WHO classification of lung tumours on histological classification of resected pulmonary NSCCs.
(
- Contribution to journal › Article
-
Mark
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Profiling cancer testis antigens in non-small-cell lung cancer
(
- Contribution to journal › Article
- 2015
-
Mark
LRIG1 is a prognostic biomarker in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma.
2015) In Applied Immunohistochemistry & Molecular Morphology(
- Contribution to journal › Article
-
Mark
Prognostic impact of COX-2 in non-small cell lung cancer: A comprehensive compartment-specific evaluation of tumor and stromal cell expression.
(
- Contribution to journal › Article
- 2014
-
Mark
Genomic and transcriptional alterations in lung adenocarcinoma in relation to smoking history.
(
- Contribution to journal › Article
-
Mark
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer
(
- Contribution to journal › Article
- 2013
-
Mark
Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to EGFR and KRAS Mutation Status.
(
- Contribution to journal › Article
-
Mark
Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
(
- Contribution to journal › Article
- 2012
-
Mark
CD99 is a novel prognostic stromal marker in non-small cell lung cancer
(
- Contribution to journal › Article
- 2011
-
Mark
Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.
(
- Contribution to journal › Article
- 2010
-
Mark
Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer.
(
- Contribution to journal › Article
-
Mark
Applicability of IG/TCR gene rearrangements as targets for minimal residual disease assessment in a population-based cohort of Swedish childhood acute lymphoblastic leukaemia diagnosed 2002-2006
(
- Contribution to journal › Article